Digital technology is rapidly changing the world of healthcare, and at Pfizer, we are harnessing this technology to live our purpose: breakthroughs that change patients’ lives. This includes providing digital health solutions that support patients when they need help the most—during their treatment journeys.

In 2022, we partnered with Walgreens to launch the Amba™ Digital Wellness Coach, an artificial intelligence (AI)-based mobile app that aims to support patients who have been prescribed IBRANCE ^® (palbociclib) for the treatment of metastatic breast cancer. When patients receive their first prescription from a Walgreens community-based specialty pharmacy, they can enroll in the app, which provides relevant education, tips, self-scheduled medication reminders, a connection with their social support network, and other useful resources as they begin their treatment. Amba can also alert the pharmacy that a patient may need outreach from the pharmacist.

Digital companions such as Amba are designed to help patients understand their medication and provide information in patient-friendly language to help minimize confusion and identify supportive resources. Over time, we anticipate that the AI capabilities developed by Catalia Health, which are a core part of the Amba app, will provide a more personalized patient experience, and we also are monitoring the program to see if it could apply to other therapeutic areas. We see this as a major step forward in the effort to use the power of digital technology to support patients.

At the heart of this effort is Pfizer’s abiding commitment to putting patients first. We know that there is so much more we can do to support patients in their treatment journeys, and we are proud to help lead the way for them, into the future of digital health.